Results 151 to 160 of about 80,065 (281)

Insilco Screening of Chloroquine Analogues for Compounds with More Affinity for the Plasmodium falciparum Chloroquine Transporter as Potential Antimalarial Drugs

, 2022
Filex Otieno, Michael Walekhwa
openalex   +1 more source

An ISO 31000-Based Risk Matrix for Risk Management in Anticancer Drug Prescription, Compounding, and Administration for Lung Cancer Patients Treated in a Day Hospital Setting. [PDF]

Risk Manag Healthc Policy
Morabito A, Maiolino P, D'Auria S, D'Aniello R, Sandomenico C, Montanino A, Casale M, Palumbo G, Sforza V, Costanzo R, Esposito G, Caropreso G, Manzo A, Capasso A, Barba B, Pannone C, Campitiello L, Nardone A, Triassi M, Damiano S, Forte CA, Rocco A, De Feo G, Tracey M, Pascarella G.   +24 more
europepmc   +1 more source

Outsourcing Human Drug Compounding [PDF]

, 2020
openaire   +1 more source

Economic Evaluation of Ready-to-Dilute Thiotepa (Tepylute^®): Institutional Cost Offsets and Time Savings Compared to Lyophilized Thiotepa in a United States Hospital Pharmacy. [PDF]

Clinicoecon Outcomes Res
Ryan O, Clancy M, MacDonald A, Pastor L, Bourque M.   +4 more
europepmc   +1 more source

Multifactorial Causes of Tacrolimus Errors: Confusion With Strength/Formulation, Look-Alike Names, Preparation Errors, and More Ensuring Safety of Recipes for Drug Compounding Please, no more teaspoon dosing. [PDF]

Hosp Pharm, 2018
Cohen MR, Smetzer JL.
europepmc   +1 more source

Supplementary Figure 2 from Unbiased Compound Screening Identifies Unexpected Drug Sensitivities and Novel Treatment Options for Gastrointestinal Stromal Tumors

, 2023
Sergei Boichuk, Derek J. Lee, Keith R. Mehalek, Kathleen R. Makielski, Agnieszka Woźniak, Danushka S. Seneviratne, Nina Korzeniewski, Rolando Cuevas, Joshua A. Parry, Matthew F. Brown, James P. Zewe, Takahiro Taguchi, Shin-Fan Kuan, Patrick Schöffski, Maria Dêbiec‐Rychter, Anette Duensing   +15 more
openalex   +1 more source

Correction: Chaachouay, N. Synergy, Additive Effects, and Antagonism of Drugs with Plant Bioactive Compounds. Drugs Drug Candidates 2025, 4, 4 [PDF]

Noureddine Chaachouay
openalex   +1 more source

From co-creation to compounding value: A new model of rare disease science communication in China. [PDF]

Intractable Rare Dis Res
Chen Y.
europepmc   +1 more source

Prevalence of subjective symptoms among hospital pharmacists and association with drug compounding practices. [PDF]

Ind Health, 2015
Inaba R, Hioki A, Kondo Y, Nakamura H, Nakamura M.   +4 more
europepmc   +1 more source

Terminal Sedation [PDF]

, 2006
Diamond, Eugene F.
core   +2 more sources